Tokyo, Japan

Yataro Daigo

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Minato-ku, JP (2010)
  • Bunkyo-ku, JP (2011 - 2012)
  • Tokyo, JP (2010 - 2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Yataro Daigo in Cancer Research

Introduction

Yataro Daigo is an esteemed inventor based in Tokyo, Japan, who has significantly contributed to the field of cancer research through his innovative inventions. With an impressive portfolio of 11 patents, Daigo has made groundbreaking strides in the diagnosis and treatment of esophageal cancer, among other malignancies.

Latest Patents

His latest inventions focus on methods for diagnosing esophageal cancer. Daigo's work includes the development of a cDNA microarray that represents 32,256 genes, utilized to analyze expression profiles of 19 esophageal squamous-cell carcinomas (ESCCs) purified by laser-capture microdissection. This research discloses a comprehensive genome-wide database of significantly up- or down-regulated genes in esophageal cancer, serving as potential therapeutic targets and diagnostic markers. Notably, among the candidate molecular target genes, ECT2, CDC45L, and DKK1 have been characterized, revealing their potential in treatment strategies. Treatment of ESCC cells with small interfering RNAs targeting ECT2 or CDC45L exhibited suppressed cancer cell growth, offering valuable insights for identifying diagnostic systems and therapeutic avenues for esophageal cancer.

Moreover, Daigo's work on the DKK1 oncogene outlines innovative approaches utilizing antibodies capable of treating cancers associated with the overexpression of DKK1. His patents include methods for cancer treatment and diagnosis, providing powerful tools for a broad spectrum of cancers, including pancreatic, gastric, liver, prostate, breast, cervical, bile duct, lung, and esophageal cancers.

Career Highlights

Yataro Daigo's career has been marked by a steadfast commitment to advancing cancer research. His affiliation with Oncotherapy Science, Incorporated, reflects his dedication to innovation in therapeutic development. Through rigorous research and development efforts, Daigo has consistently contributed to enhancing our understanding of cancer and paving the way for effective treatment options.

Collaborations

Throughout his career, Daigo has collaborated with notable colleagues such as Shuichi Nakatsuru and Yusuke Nakamura. These collaborations have further enriched his research endeavors and helped push the boundaries of cancer diagnostics and therapeutics.

Conclusion

In summary, Yataro Daigo stands as a notable figure in the realm of cancer research, with a strong portfolio of patents that highlight his commitment to innovation and improvement in cancer diagnosis and treatment. His contributions not only enhance scientific knowledge but also hold the potential to impact patient care significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…